| Literature DB >> 30393426 |
Andrea K Finlay1,2, Ingrid Binswanger3,4, Christine Timko1,5, Joel Rosenthal6, Sean Clark7, Jessica Blue-Howells8, Jim McGuire8, Hildi Hagedorn9, Jessie Wong1,5, James Van Campen1, Alex H S Harris1.
Abstract
This study examined whether, among Veterans Health Administration (VHA) patients, veterans with recent or current justice involvement have equal receipt of pharmacotherapy for alcohol use disorder compared to veterans with no justice involvement. Using national VHA records, we calculated the overall and facility rates of receipt as the number of patients who received pharmacotherapy for alcohol use disorder divided by the number of patients diagnosed with an alcohol use disorder. Using a mixed-effects logistic regression model, we tested whether justice involvement was associated with pharmacotherapy receipt. Male veterans with jail/court involvement had significantly higher odds of receiving pharmacotherapy for alcohol use disorder compared to other male veterans. Justice-involved veterans had equal or better receipt of pharmacotherapy for alcohol use disorder compared to veterans with no justice involvement. Pharmacotherapy rates are low overall, suggesting that more work can be done to connect veterans to these medications.Entities:
Keywords: Alcohol-related disorders; Criminal Justice; Naltrexone; Topiramate; United States Department of Veterans Affairs
Year: 2016 PMID: 30393426 PMCID: PMC4852381 DOI: 10.1177/0887403416644011
Source DB: PubMed Journal: Crim Justice Policy Rev ISSN: 0887-4034